WAYNE, PA — Liam Kelly, Chairman, President and CEO of Teleflex Incorporated (NYSE: TFX), is set to take the stage at the 42nd Annual J.P. Morgan Healthcare Conference. The event, a staple in the healthcare industry’s calendar, will be held at The Westin St. Francis in San Francisco, California.
Kelly, who has been steering the medical technology company with revenues exceeding $2.4 billion, is scheduled to speak on Tuesday, January 9, 2024, at 3:00 p.m. Pacific Time. The highly respected executive is expected to provide insights into the company’s growth strategy and its approach to innovation in the medical technology sector.
Teleflex, listed under the ticker symbol TFX on the New York Stock Exchange, has carved out a niche in the medtech space with its diversified portfolio. The company’s commitment to “purpose driven innovation” – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers has paid off in the form of steady growth.
The presentation by Kelly holds significance as it comes amidst a dynamic healthcare environment. Investors and industry observers will be keenly following his address for cues on the company’s strategic direction and its plans to navigate the changing landscape.
In a move to ensure wider accessibility, Teleflex will be providing a live audio webcast of Kelly’s conference presentation. An accompanying slide presentation will also be available. Both can be accessed from the investor section of the Teleflex website.
The J.P. Morgan Healthcare Conference has long been a platform for companies to share their vision and strategies. As Kelly prepares to share Teleflex’s growth story and future roadmap, the event promises to offer valuable insights into the company’s journey and its plans for the future.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.